Craft

3sbio

Stock Price

$6.1

2024-04-26

Market Capitalization

$14.8 B

2024-04-26

Revenue

¥7.8 B

FY, 2023

3sbio Summary

Company Summary

Overview
3sbio (三生制药集团) is a company that develops biopharmaceuticals. Its product lineup covers several treatment fields including cancer, autoimmune, kidney disease, metabolism, and dermatology.
Type
Public
Status
Active
Founded
1993
HQ
Shenyang, CN | view all locations
Website
http://www.3sbio.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Shenyang, Liaoning HQ

    China

    No. 1A 3, No. 10 Road

3sbio Financials

Summary Financials

Revenue (FY, 2023)
¥7.8B
Gross profit (FY, 2023)
¥7.1B
Net income (FY, 2023)
¥1.6B
Cash (FY, 2023)
¥2.7B
EBIT (FY, 2023)
¥2.4B
Enterprise value
$17.0B

Footer menu